FDA recall D-0223-2024

Dr. Reddy's Laboratories, Inc. · Class II · drug

Product

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

Reason for recall

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

Distribution

USA Nationwide

Key facts

Status
Completed
Initiation date
2024-01-02
Report date
2024-01-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0223-2024